Organon OGN Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $574M-15.0% | $675M-2.6% | $693M-1.8% | $706M-4.2% | ||
| $5.76B-7.3% | $6.21B-4.6% | $6.51B+13.7% | $5.73B+6.1% | ||
| $930M+66.4% | $559M+42.6% | $392M+21.0% | $324M+16.5% | ||
| $4.35B+0.1% | $4.35B-3.5% | $4.51B+14.7% | $3.93B+4.5% | ||
| $1.3B+11.6% | $1.17B-1.3% | $1.18B+16.2% | $1.02B+4.6% | ||
| $4.15B-11.3% | $4.68B+1.7% | $4.6B0.0% | $4.6B0.0% | ||
| $1.13B-20.1% | $1.41B+165% | $533M-17.9% | $649M-0.3% | ||
| $12.87B-1.8% | $13.1B+8.6% | $12.06B+10.1% | $10.96B+2.6% | ||
| $952M-17.4% | $1.15B-12.3% | $1.31B+16.1% | $1.13B-18.1% | ||
| $16M-20.0% | $20M+122% | $9M+12.5% | $8M-11.1% | ||
| $2.39B-12.1% | $2.72B-6.9% | $2.92B+16.2% | $2.51B-3.3% | ||
| $8.63B-2.6% | $8.86B+1.2% | $8.75B-1.7% | $8.91B-2.4% | ||
| $12.12B-4.1% | $12.63B+4.1% | $12.13B+2.4% | $11.85B— | ||
| 500M+16,567% | 3M0.0% | 3M0.0% | 3M0.0% | ||
| $1.11B+9.8% | $1.01B+128% | $443M+234% | -$331M+66.8% | ||
| $752M+59.3% | $472M+774% | -$70M+92.2% | -$892M+40.8% | ||
| $12.87B-1.8% | $13.1B+8.6% | $12.06B+10.1% | $10.96B+2.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Organon cover its short-term obligations?
- Its current ratio is 1.97 — current assets exceed current liabilities.
- Where does Organon's balance sheet data come from?
- Every line is extracted from Organon's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.